FDA
approval
· 2023-03-20
FDA Approved: TAZAROTENE — Original Application (Solaris Pharma Corporation)
Summary
The FDA approved a generic version of tazarotene (topical retinoid) from Solaris Pharma Corporation through an Original Abbreviated New Drug Application (ANDA 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TAZAROTENE (TAZAROTENE)